Minnesota Rewrites Its Cannabis Playbook With Sweeping Omnibus Overhaul

Minnesota Just Passed the Most Ambitious State Cannabis Reform of 2026

While national attention has focused on federal rescheduling and the DEA's June 29 hearing, Minnesota quietly passed what may be the most consequential state-level cannabis legislation of the year. Governor Tim Walz signed the omnibus cannabis bill into law in late May, fundamentally restructuring how the state regulates cannabis cultivation, manufacturing, retail, and the relationship between its cannabis and hemp industries.

The bill doesn't just tweak existing rules. It creates new license categories, merges previously separate supply chains, raises product potency limits, and—most notably—builds a regulatory bridge for hemp businesses facing extinction from the federal THC ban. It's a comprehensive rethinking of how a state cannabis program should work.

The Macrobusiness License

The headline provision is the creation of a cannabis macrobusiness license, replacing the existing medical combination business license effective January 1, 2027.

Under the old system, medical cannabis operators in Minnesota held combination licenses that allowed them to cultivate, manufacture, and sell cannabis products. But these licenses came with significant constraints and operated under rules designed for a medical-only market.

The new macrobusiness license is designed for the reality of a dual-use market. License holders can cultivate up to 38,000 square feet of mature, flowering plants indoors—a substantial reduction from the 90,000 total square feet allowed under the previous medical combination license. The cultivation limit increases annually upon license renewal, up to a maximum of 45,000 square feet.

Macrobusinesses can operate up to eight retail stores. But there's a community access requirement: if a macrobusiness operates more than five locations, at least three must be located in areas of "high medical need" as identified by the Office of Cannabis Management. This provision ensures that the largest operators can't simply concentrate their retail presence in high-traffic urban locations while ignoring underserved communities.

The design reflects lessons learned from other states. The cultivation cap prevents the race-to-the-bottom overproduction that crashed prices in Oregon and Michigan. The retail limit with geographic requirements balances market access against consolidation. And the phased cultivation increases give the market time to mature without oversupply.

Merging the Supply Chains

Perhaps the most operationally significant change is the merger of Minnesota's medical and adult-use cannabis supply chains.

Until now, businesses serving both medical patients and recreational consumers had to maintain completely separate cultivation, manufacturing, and inventory tracking systems. This included running separate instances of Minnesota's Metrc seed-to-sale tracking platform—essentially operating two parallel businesses under one roof.

The cost and complexity were enormous. Duplicating cultivation facilities, manufacturing equipment, packaging lines, and tracking systems meant that operators serving both markets bore roughly double the overhead of a single-market operator.

The omnibus bill eliminates this requirement. Under the new framework, the only distinction between medical and recreational cannabis occurs at the point of sale. Medical cannabis products receive a sticker identifying them as medical and are sold tax-free to registered patients. Everything upstream—growing, processing, testing, and distributing—operates through a single integrated supply chain.

For operators, this change immediately improves economics. Consolidated cultivation means better resource utilization. Unified manufacturing means higher throughput on existing equipment. Single-instance tracking means reduced compliance costs and fewer opportunities for data errors.

For patients, it means access to the full recreational product menu at medical prices—without the taxes. The merger effectively expands the medical product selection while reducing the cost of serving medical patients.

The Hemp Bridge

The most forward-thinking provision in Minnesota's bill addresses a crisis that most states have ignored entirely: what happens to hemp businesses when the federal THC ban takes effect.

With the November 12, 2026 deadline approaching—when hemp products containing more than 0.4 milligrams of total THC per container become illegal under federal law—hemp businesses nationwide face an existential threat. Most states have offered no pathway for these businesses to transition into state-licensed cannabis programs.

Minnesota took a different approach. The omnibus bill explicitly allows a person, cooperative, or business holding a hemp business license to also hold a cannabis license. This dual-licensing provision creates a regulatory bridge for hemp operators to cross into the cannabis market without starting from scratch.

The practical implications are significant. A hemp manufacturer with established extraction equipment, testing protocols, product formulations, and retail relationships can apply for a cannabis license and begin operating in the regulated cannabis market using much of their existing infrastructure and expertise. They don't need to abandon their investment and rebuild from zero.

This isn't just good policy for hemp businesses—it's good policy for the cannabis market. Hemp operators bring manufacturing experience, product development knowledge, and often established brands and customer bases. Integrating them into the cannabis market strengthens the overall industry rather than creating a disruptive cliff where experienced operators suddenly become illegal.

Edible Potency Changes

The bill also raises milligram caps for cannabis food and beverage products. Edibles can now contain up to 200 milligrams of THC per package, a significant increase from previous limits.

This change reflects both market reality and consumer demand. Many experienced consumers find lower-potency packages inadequate, requiring multiple purchases to meet their needs—an inconvenience that drives some toward unregulated products. Higher per-package limits reduce packaging waste, lower per-milligram costs for consumers, and bring Minnesota's regulations closer to national norms.

The change comes with continued per-serving limits and child-resistant packaging requirements, maintaining consumer safety guardrails while expanding product options.

What Other States Can Learn

Minnesota's omnibus bill matters beyond its borders because it addresses several problems that other states have either ignored or handled poorly.

The supply chain merger problem is nearly universal. Every state with both medical and recreational programs has faced the question of whether to maintain separate supply chains. Minnesota's decisive integration, with a simple sticker-based distinction at point of sale, offers an elegant and cost-effective model.

The hemp bridge concept is immediately relevant as November 2026 approaches. States with significant hemp industries—and that's most of them—need to decide whether to let those businesses die or provide a pathway into regulated cannabis. Minnesota's approach could serve as a template.

The macrobusiness license structure, with its cultivation caps, retail limits, and geographic requirements, represents a considered middle ground between the restrictive licensing that has choked some states' markets and the permissive approach that has crashed others.

Implementation Challenges

The bill isn't a magic wand. Implementation will require the Office of Cannabis Management to develop new rules, application processes, and compliance systems on an aggressive timeline. The January 1, 2027 effective date for macrobusiness licenses leaves roughly seven months for regulatory development—tight, but feasible with adequate resources.

The hemp bridge provision will also need careful implementation to prevent regulatory arbitrage, where hemp businesses obtain cannabis licenses primarily to access a different tax or regulatory treatment without genuinely transitioning their operations.

And like every cannabis market, Minnesota will face the ongoing challenge of balancing tax revenue, market access, social equity, public health, and industry viability—competing priorities that no single piece of legislation can perfectly resolve.

The Bigger Picture

Minnesota's omnibus bill represents what proactive cannabis governance looks like. Rather than waiting for problems to become crises, the state identified structural inefficiencies in its market, anticipated the impact of federal hemp policy changes, and acted comprehensively.

Not every provision will work as intended. Not every stakeholder is satisfied. But the willingness to reform a cannabis program that is barely two years old—to acknowledge what isn't working and fix it before it calcifies—sets Minnesota apart from states that have let market dysfunction persist for years before acting.

In a year dominated by federal rescheduling drama and the hemp ban countdown, Minnesota quietly demonstrated that the most meaningful cannabis reform in 2026 might be happening at the state level.